Acunetix vs ImmuniWeb comparison

"For us, the most valuable aspect of the solution is the log-sequence feature."

"I find it to be one of the most comprehensive tools, with support for manual intervention."

"Our developers can run the attacks directly from their environments, desktops."

"It generates automated reports."

"It can operate both as a standalone and it can be integrated with other applications, which makes it a very versatile solution to have."

"The usability and overall scan results are good."

"One of the features that I feel is groundbreaking, that I would like to see expanded on, is the IAS feature: The Interactive Application Security Testing module that gets loaded onto an application on a server, for more in-depth, granular findings. I think that is really neat. I haven't seen a lot of competitors doing that."

"Acunetix is the best service in the world. It is easy to manage. It gives a lot of information to the users to see and identify problems in their site or applications. It works very well."

"After the assessment, you clearly know which assets require penetration testing."

"The initial setup process is user-friendly."

"I like the fully automated continuous discovery run by ImmuniWeb in the background. We do not need to rerun the same tests or the same scanning against our resources. We need to supply our IP addresses, domain names, and significant resources with special domain names and URLs, and we need to do it only once. Then we always have an up-to-date picture. I also like the integration with our single sign-on system. We do not need to maintain a separate set of usernames or user accounts. We can plug this ImmuniWeb service into our authentication technology, enabling two-factor authentication. We have secure authentication right out of the box. The other important feature I like is the executive view. You can easily switch from a technical view to an executive view and have a helicopter view of the compliance status. We can see how much effort is required and our current status."

"The solution's most valuable feature is reporting."

"The most valuable features are the SLA of Zero false-positives, less time of service development, validation of unlimited patched vulnerabilities, and several others."

"ImmuniWeb boasts a robust vulnerability detection mechanism, formidable threat mitigation, and an efficient remediation process, incorporating automation techniques and ALM strategies. The solution is highly stable. The solution is scalable. Editing Key Points for Review "Review about ImmuniWeb" What is our primary use case? We use the solution when we face challenges and urgent attention is needed for complex cases from our clients. To address this, we collaborate with the middleware, internal, and client teams to analyze and sort through intricate logs concerning our business cybersecurity program. How has it helped my organization? The solution helped us with one of our clients in the New York area contacted us about a data breach. In response, we swiftly organized a case meeting involving our client, internal, and email customer support teams. Together, we conducted an incident response, facilitating offline assistance for proper planning and risk management processes. We delved into the details of the data breach, identified how it occurred, and collaborated to rectify the issue. The client expressed satisfaction with the resolution process. What is most valuable? ImmuniWeb boasts a robust vulnerability detection mechanism, formidable threat mitigation, and an efficient remediation process, incorporating automation techniques and ALM strategies. It also focuses on consumer satisfaction and operates in English-speaking markets, primarily required by the UAE, the United States, Canada, and Australia, among other developed countries. For how long have I used the solution? We have been using this product for the past one and half years. What do I think about the stability of the solution? The solution is highly stable. I rate it a perfect ten. What do I think about the scalability of the solution? The solution is scalable. I rate it a nine out of ten. How are customer service and support? Support is generally excellent"

"ImmuniWeb is stable."

"Acunetix needs to include agent analysis."

"We want to see how much bandwidth usage it consumes. When we monitor traffic we have issues with the consumption and throttling of the traffic."

"The cost can be reduced as management has noted it to be on the higher side."

"We have had issues during upgrades where their scans worked on some apps better with previous versions. Then, we had to work with their tech support, who were great, to get it fixed for the next version."

"The jargon used makes it difficult for project managers to understand the issues, and the technical explanations used make it difficult for developers to understand issues. These things should be simplified much more. That would be very helpful for us when explaining to them what needs to be fixed. The report output needs to be simplified."

"In terms of what needs improvement, the way the licensing model is currently is not very convenient for us because initially, when we bought it, the licensing model was very flexible, but now it restricts us."

"There's a clear need for a reduction in pricing to make the service more accessible."

"It should be easier to recreate something manually, with the manual tool, because Acunetix is an automatic tool. If it finds something, it should be easier to manually replicate it. Sometimes you don't get the raw data from the input and output, so that could be improved."

"The product’s interface for the web applications could be similar to Android and iOS versions."

"ImmuniWeb sometimes shows previous scans instead of running tests."

"It would be better if they had an automated tagging feature. The tagging functionality currently requires manual tagging, and that's probably the most needed feature from my standpoint. We also do not have enough tools, enough features, or options to display different resources in the way we need. There are basic grouping and some filtering features, but we still cannot fully separate some flavors of our resources. However, we may not be aware of the latest features."

"Its technical support could be better."

"A great idea would be to support using Discovery on the internal network, allowing delivery of all the features of the current Discovery to internal network resources."

"A great idea would be to make a mobile application for the ImmuniWeb portal so that all information would be available on the go and from a mobile phone as well. It would be much more convenient."

"The deployment process on the cloud is straightforward, while on-premise can be complex. Support is generally excellent, although there can be delays in ticket resolution."

"The price is exceptionally high."

"When compared with other products, the pricing is a little bit high. But it gives value for the price. It serves the purpose and is worthwhile for the price we pay."

"All things considered, I think it has a good price/value ratio."

"The pricing is a little high, and moreover, it's kind of domain-based."

"Acunetix was around the same price as all the other vendors we looked at, nothing special."

"The solution is expensive."

"The cost is based on two types of licenses, ConsultLite, and ConsultPlus, as well as the number of domains that are scanned."

"The costs aren't very expensive. It costs around $3000 or $4000."

"I use the product's free version. The tool costs around 229 dollars."

"ImmuniWeb is relatively cheap. It's a competitive price compared to other products in the marketplace. It's worth the money we are paying for it."

"The platform is expensive if a large development is involved. However, it is less expensive for scheduled-based testing, quarterly or in a year."

"It is pretty expensive."

"It is pretty expensive."

"There should be the flexibility to change or add pricing, especially for pay-per-use cases."

"The values of ImmuniWeb are currently significantly below what is valued in the Chilean market for these services and solutions."